Nutrastar International (NUIN) Return on Assets ROA from the third quarter of 2015 to third quarter of 2014 and for the year 2015, Average High and Low, Fundamental Ratios from Sep 30 2015 to Sep 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nutrastar International Inc.  (NUIN)


Nutrastar International's ROA from the third quarter of 2015 to the third quarter of 2014 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Nutrastar International's ROA in the third quarter of 2015?
Nutrastar International Inc. achieved a return on average assets (ROA) of 15.53 % in its third quarter of 2015, which is below Nutrastar International's average return on assets, which stands at 18.36%.

ROA decreased relative to the period ending Jun 30 2015, due to the decline in net income.

However, within the Healthcare sector 55 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2015 from 379 to 390.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Total Assets Change 13.44 % 18.79 % 19.34 % 18.61 % 20.56 %
Y / Y Net Income Change -1.13 % 4.15 % 9.2 % -5.44 % 4.83 %
Net Income (TTM) in million 23 23 23 23 23
Return On Assets (TTM) 15.53 % 16.07 % 16.57 % 17.08 % 18.14 %
NUIN's Total Ranking # 390 # 379 # 395 # 396 # 514
Total Assets (TTM) in million 154 155 145 144 136
Seq. Total Assets Change -0.21 % 6.48 % 1.08 % 5.62 % 4.5 %
Seq. Net Income Change -15.35 % 100.44 % -46.75 % 9.43 % -10.83 %

NUIN's 5 Years Annual ROA >> Back to NUIN Management Effectiveness >> Compare NUIN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 56
Overall # 297

Return On Assets Statistics
High Average Low
20.21 %
18.36 %
15.53 %
(Dec 31 2013)   (Sep 30 2015)





Financial Statements
Nutrastar International's Assets $ 154 million NUIN's Balance sheet
Nutrastar International's Income $ 6 million Quarterly NUIN's Income Statement
NUIN's Income by Division See NUIN's Income by Division



Annual Return On Assets (Dec 31 2014)
FY 2014		 (Dec 31 2013)
FY 2013		 (Dec 31 2012)
FY 2012		 (Dec 31 2011)
FY 2011
FY
Y / Y Total Assets Change 18.61 % 27.03 % 24.87 % - -
Total Assets in million 144 121 95 76 0
Y / Y Net Income Change 2.48 % 28.58 % 1.53 % - -
Net Income in million 23 22 17 17 0
Annual Return On Assets 15.8 % 18.29 % 18.07 % 22.22 % -

NUIN's 5 Years Annual ROA >> Back to NUIN Management Effectiveness >> Compare NUIN ROA to its Competitors



Comment on NUIN's ROA in the fiscal year ending 2014
In the fiscal year 2014 ROA deteriorated to 15.8 %, despite annual net income growth of 2.48 % to $22.72 million, from $22.17 million a year ago, as NUIN's assets increase to $143.80 million, by 2.48 %.


More Return On Assets Ratios
NUIN's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NUIN's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NUIN's Competitors
Subscribers only: Roa for Nutrastar International's Suppliers
Subscribers only: Return On Assets for NUIN's Customers

You may also want to know
NUIN's Roi NUIN's Inventory Turnover Ratio NUIN's Growth Rates NUIN's Dividend Comparisons
NUIN's Profitability Ratios NUIN's Asset Turnover Ratio NUIN's Dividend Growth
NUIN's Roe NUIN's Valuation Ratios NUIN's Financial Strength Ratios NUIN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2015, within Healthcare Sector ROA
Gilead Sciences Inc   41.48 %
Abiomed Inc   39.29 %
Corbus Pharmaceuticals Holdings Inc   36.36 %
United Therapeutics Corporation  35.76 %
Enanta Pharmaceuticals Inc  35.70 %
Pacific Health Care Organization Inc  33.61 %
Lannett Company Inc  30.59 %
Travere Therapeutics Inc   24.37 %
Biospecifics Technologies Corp  24.17 %
China Biologic Products Holdings Inc   23.11 %
Biogen Inc   21.81 %
Vanda Pharmaceuticals Inc   21.53 %
Iridex Corp  21.22 %
Journey Medical Corp  21.01 %
Misonix Inc   20.88 %
Fonar Corporation  20.46 %
National Healthcare Corp  19.86 %
Sientra Inc   19.79 %
Meridian Bioscience Inc   19.79 %
Lakeland Industries Inc   18.17 %
Atrion Corporation  17.71 %
Mimedx Group Inc   17.49 %
Tenax Therapeutics Inc   17.45 %
Oramed Pharmaceuticals Inc  17.44 %
Mettler toledo International Inc   17.24 %
Proteo Inc  17.05 %
Cba Florida Inc   16.21 %
Paratek Pharmaceuticals Inc   15.91 %
3m Company  15.74 %
Resmed Inc   15.53 %

Date modified: 2026-09-26T07:15:13+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.